Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(3 sites)
Russia
Moscow Multidiciplinary Clinical Center Kommunarka, Moscow N.N Blokhin Cancer Reserch Center, Moscow Reutov Clinical hospital, Reutov Age range
18 Years – 99 Years
Last updated January 2024